{"id":63375,"date":"2022-05-06T14:37:05","date_gmt":"2022-05-06T12:37:05","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=63375"},"modified":"2023-10-10T07:17:56","modified_gmt":"2023-10-10T07:17:56","slug":"toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/","title":{"rendered":"Toxina botul\u00ednica A: aspectes diferencials entre diverses presentacions"},"content":{"rendered":"\n<p>El passat <strong>28 d&#8217;abril<\/strong> va tenir lloc al <strong>Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB)<\/strong> la formaci\u00f3 <strong>&#8220;Aspectes diferencials entre diverses presentacions de toxina botul\u00ednica A&#8221;<\/strong>, patrocinada per <strong><a href=\"https:\/\/www.ipsen.com\/spain\/\" target=\"_blank\" rel=\"noreferrer noopener\">Ipsen<\/a><\/strong>. <strong>David Conde<\/strong>, vocal d&#8217;Hospitals del COFB, va ser l&#8217;encarregat de coordinar aquesta sessi\u00f3, que va comptar amb la participaci\u00f3 de <strong>M. Teresa Tejerina<\/strong>, catedr\u00e0tica de farmacologia de la Facultat de Medicina de la Universitat Complutense de Madrid; <strong>Helena Bascu\u00f1ana<\/strong>, directora del Servei de Medicina F\u00edsica i Rehabilitaci\u00f3 de l\u2019Hospital de la Santa Creu i Sant Pau; i <strong>Laura Villamarin<\/strong>, farmac\u00e8utica del Servei de Farm\u00e0cia de l\u2019Hospital de la Santa Creu i Sant Pau. <\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/05\/COFB_Toxines-botuliniques_280422_3-1024x574.jpg\" alt=\"Helena Bascu\u00f1ana, en un moment de la formaci\u00f3 &quot;Aspectes diferencials entre diverses presentacions de toxina botul\u00ednica A&quot;.\" class=\"wp-image-63449\" title=\"Helena Bascu\u00f1ana, en un moment de la formaci\u00f3 &quot;Aspectes diferencials entre diverses presentacions de toxina botul\u00ednica A&quot;.\"\/><figcaption class=\"wp-element-caption\">Helena Bascu\u00f1ana, en un moment de la formaci\u00f3 &#8220;Aspectes diferencials entre diverses presentacions de toxina botul\u00ednica A&#8221;.<\/figcaption><\/figure>\n\n\n\n<p>&#8220;La toxina botul\u00ednica tipus A est\u00e0 <strong>present en diferents camps de la medicina <\/strong>amb <strong>multitud d&#8217;indicacions<\/strong>, \u00e9s per aix\u00f2 que hem cregut convenient fer un rep\u00e0s de diferents aspectes relacionats al voltant d&#8217;aquesta tem\u00e0tica&#8221;, va introduir el vocal d&#8217;Hospitals del COFB. M\u00e9s concretament, els objectius d&#8217;aquesta activitat formativa eren saber <strong>diferenciar les diferents formulacions <\/strong>d&#8217;aquesta toxina, con\u00e8ixer les <strong>indicacions de cada presentaci\u00f3 <\/strong>i comprendre les <strong>difer\u00e8ncies farmacoecon\u00f2miques<\/strong>. <\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong><strong>Difer\u00e8ncies entre els diversos productes comercialitzats des del punt de vista farmacol\u00f2gic<\/strong><\/strong><\/h2>\n\n\n\n<p>A la primera part de la formaci\u00f3, la catedr\u00e0tica de farmacologia <strong>M. Teresa Tejerina<\/strong> va comen\u00e7ar la seva intervenci\u00f3 fent una introducci\u00f3 sobre els <strong>f\u00e0rmacs biol\u00f2gics <\/strong>i, a continuaci\u00f3, va abordar les <strong>difer\u00e8ncies entre els diversos productes comercialitzats de toxina botul\u00ednica tipus A (BoNT-A) des del punt de vista farmacol\u00f2gic.<\/strong><\/p>\n\n\n<div class=\"destacat-blog\">\n\n\n<p>A causa del <strong>complex proc\u00e9s de fabricaci\u00f3<\/strong> que implica el seu desenvolupament i producci\u00f3, les <strong>toxines botul\u00edniques<\/strong> poden presentar <strong>difer\u00e8ncies substancials entre elles. <\/strong>Durant el proc\u00e9s de fabricaci\u00f3, cada companyia t\u00e9 la seva pr\u00f2pia soca parental bacteriana i les seves pr\u00f2pies condicions de producci\u00f3, donant com a resultat un fenotip diferent de toxina botul\u00ednica.<\/p> <\/div>\n\n\n\n<p>Durant la seva explicaci\u00f3, tamb\u00e9 va tractar altres aspectes, com l&#8217;<strong>estructura de la toxina botul\u00ednica A <\/strong>i el seu <strong>mecanisme d&#8217;acci\u00f3<\/strong>, els <strong>diferents processos de fabricaci\u00f3 que generen preparats de BoNT-A amb caracter\u00edstiques diferents<\/strong> i, finalment, els <strong>estudis farmacol\u00f2gics <\/strong>existents. <\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/05\/COFB_Toxines-botuliniques_280422_4-1024x580.jpg\" alt=\"Laura Villamarin va fer un rep\u00e0s de diferents estudis de farmacoeconomia.  \" class=\"wp-image-63450\" title=\" Laura Villamarin va fer un rep\u00e0s de diferents estudis de farmacoeconomia.  \"\/><figcaption class=\"wp-element-caption\"> Laura Villamarin va fer un rep\u00e0s de diferents estudis de farmacoeconomia.  <\/figcaption><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Diferenciaci\u00f3 cl\u00ednica i aspectes farmacoecon\u00f2mics de cada presentaci\u00f3<\/strong><\/h2>\n\n\n\n<p>La segona part de l&#8217;activitat formativa es va centrar en la <strong>diferenciaci\u00f3 cl\u00ednica i els aspectes farmacoecon\u00f2mics de cada presentaci\u00f3<\/strong>. D&#8217;una banda, <strong>Helena Bascu\u00f1ana<\/strong> va parlar de les <strong>indicacions i els usos <\/strong>de la toxina, les<strong> dosis segons el m\u00fascul<\/strong> i les <strong>guies i recomanacions<\/strong> a seguir. D&#8217;altra banda,  <strong>Laura Villamarin<\/strong> va fer un rep\u00e0s de diferents<strong> estudis de farmacoeconomia<\/strong>. <\/p>\n\n\n<div class=\"destacat-blog\">\n\n\n<h3 class=\"wp-block-heading\"><strong>Indicacions terap\u00e8utiques de la toxina botul\u00ednica<\/strong><\/h3>\n\n\n\n<p>Les indicacions terap\u00e8utiques de la toxina botul\u00ednica s\u00f3n diverses i per a diferents camps de la medicina: <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n\n<li><strong>Trastorns neurol\u00f2gics <\/strong>(espasticitat focal, blefaroespasme, espasme hemifacial, distonia cervical i alleugeriment de s\u00edmptomes en adults que compleixen els criteris de migranya cr\u00f2nica)<\/li>\n\n\n<li><strong>Trastorns vesicals<\/strong> (bufeta hiperactiva idiop\u00e0tica, incontin\u00e8ncia urin\u00e0ria en adults) <\/li>\n\n\n<li><strong>Trastorns de la pell i \u00f2rgans annexos<\/strong> (hiperhidrosi prim\u00e0ria de l\u2019aixella)<\/li>\n\n<\/ul><\/div>\n\n\n\n<p>A partir de les explicacions de les dues ponents, les <strong>principals conclusions <\/strong>que es van extreure van ser que <strong>la toxina botul\u00ednica A \u00e9s l&#8217;opci\u00f3 de tractament preferent en moltes indicacions <\/strong>i que <strong>existeixen difer\u00e8ncies entre les toxines i les<\/strong> <strong>condicions d&#8217;\u00fas te\u00f2riques i reals<\/strong>. Aix\u00ed mateix, es va traslladar que <strong>una selecci\u00f3 adequada de les toxines segons la indicaci\u00f3 permet estalviar despeses al sistema sanitari<\/strong> i es va fer \u00e8mfasi en la<strong> necessitat d&#8217;adaptar les avaluacions farmacoecon\u00f2miques a la realitat de cada hospital. <\/strong><\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"has-text-align-right\"><strong>Activitat organitzada conjuntament amb<\/strong><\/p>\n\n\n\n<div class=\"wp-block-uagb-image aligncenter uagb-block-ee33298a wp-block-uagb-image--layout-default wp-block-uagb-image--effect-static wp-block-uagb-image--align-center\"><figure class=\"wp-block-uagb-image__figure\"><img loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/10\/societat-catalana-farmacia-2-300x195.png \" sizes=\"auto, (max-width: 480px) 150px\" src=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/10\/societat-catalana-farmacia-2-300x195.png\" alt=\"\" class=\"uag-image-69043\" width=\"300\" height=\"195\" title=\"\" loading=\"lazy\"\/><\/figure><\/div>\n\n\n\n<p class=\"has-text-align-right\"><strong>Amb el patrocini de:<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image alignright size-thumbnail\"><a href=\"https:\/\/www.ipsen.com\/spain\/\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/05\/IPSEN_logo_transparent-150x45.png\" alt=\"\" class=\"wp-image-63400\"\/><\/a><\/figure>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>El passat 28 d&#8217;abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 &#8220;Aspectes diferencials entre diverses presentacions de toxina botul\u00ednica A&#8221;, patrocinada per Ipsen. David Conde, vocal d&#8217;Hospitals del COFB, va ser l&#8217;encarregat de coordinar aquesta sessi\u00f3, que va comptar amb la participaci\u00f3 de M. Teresa [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":67914,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[18,19,53,68,69,713,714,70,715,76,716,717,718],"class_list":["post-63375","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-farmaceutics","tag-farmacia","tag-farmacia-comunitaria","tag-farmacs-biologics","tag-farmaeconomia","tag-formacio","tag-indicacions-terapeutiques","tag-oficina-de-farmacia","tag-toxina-botulinica","tag-toxina-botulinica-a","tag-toxines"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Toxina botul\u00ednica A: aspectes diferencials entre diverses presentacions - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 28 d&#039;abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 &quot;Aspectes diferencials entre diverses presentacions de toxina botul\u00ednica A&quot; amb l&#039;objectiu de saber diferenciar les diferents formulacions, con\u00e8ixer les indicacions de cada presentaci\u00f3 i comprendre les difer\u00e8ncies farmaecon\u00f2miques.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Toxina botul\u00ednica A: aspectes diferencials entre diverses presentacions - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 28 d&#039;abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 &quot;Aspectes diferencials entre diverses presentacions de toxina botul\u00ednica A&quot; amb l&#039;objectiu de saber diferenciar les diferents formulacions, con\u00e8ixer les indicacions de cada presentaci\u00f3 i comprendre les difer\u00e8ncies farmaecon\u00f2miques.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-06T12:37:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-10T07:17:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2023\/07\/COFB_Toxines-botuliniques_280422_3-1024x574-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"574\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Toxina botul\u00ednica A: aspectes diferencials entre diverses presentacions\",\"datePublished\":\"2022-05-06T12:37:05+00:00\",\"dateModified\":\"2023-10-10T07:17:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/\"},\"wordCount\":664,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Toxines-botuliniques_280422_3-1024x574-1.jpg\",\"keywords\":[\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"farmac\u00e8utics\",\"Farm\u00e0cia\",\"farm\u00e0cia comunit\u00e0ria\",\"f\u00e0rmacs biol\u00f2gics\",\"farmaeconomia\",\"Formaci\u00f3\",\"indicacions terap\u00e8utiques\",\"Oficina de farm\u00e0cia\",\"toxina botul\u00ednica\",\"toxina botul\u00ednica a\",\"toxines\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/\",\"name\":\"Toxina botul\u00ednica A: aspectes diferencials entre diverses presentacions - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Toxines-botuliniques_280422_3-1024x574-1.jpg\",\"datePublished\":\"2022-05-06T12:37:05+00:00\",\"dateModified\":\"2023-10-10T07:17:56+00:00\",\"description\":\"El passat 28 d'abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 \\\"Aspectes diferencials entre diverses presentacions de toxina botul\u00ednica A\\\" amb l'objectiu de saber diferenciar les diferents formulacions, con\u00e8ixer les indicacions de cada presentaci\u00f3 i comprendre les difer\u00e8ncies farmaecon\u00f2miques.\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Toxines-botuliniques_280422_3-1024x574-1.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Toxines-botuliniques_280422_3-1024x574-1.jpg\",\"width\":1024,\"height\":574},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Toxina botul\u00ednica A: aspectes diferencials entre diverses presentacions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Toxina botul\u00ednica A: aspectes diferencials entre diverses presentacions - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 28 d'abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 \"Aspectes diferencials entre diverses presentacions de toxina botul\u00ednica A\" amb l'objectiu de saber diferenciar les diferents formulacions, con\u00e8ixer les indicacions de cada presentaci\u00f3 i comprendre les difer\u00e8ncies farmaecon\u00f2miques.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/","og_locale":"ca_ES","og_type":"article","og_title":"Toxina botul\u00ednica A: aspectes diferencials entre diverses presentacions - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 28 d'abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 \"Aspectes diferencials entre diverses presentacions de toxina botul\u00ednica A\" amb l'objectiu de saber diferenciar les diferents formulacions, con\u00e8ixer les indicacions de cada presentaci\u00f3 i comprendre les difer\u00e8ncies farmaecon\u00f2miques.","og_url":"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2022-05-06T12:37:05+00:00","article_modified_time":"2023-10-10T07:17:56+00:00","og_image":[{"width":1024,"height":574,"url":"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2023\/07\/COFB_Toxines-botuliniques_280422_3-1024x574-1.jpg","type":"image\/jpeg"}],"author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"4 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Toxina botul\u00ednica A: aspectes diferencials entre diverses presentacions","datePublished":"2022-05-06T12:37:05+00:00","dateModified":"2023-10-10T07:17:56+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/"},"wordCount":664,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Toxines-botuliniques_280422_3-1024x574-1.jpg","keywords":["COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","farmac\u00e8utics","Farm\u00e0cia","farm\u00e0cia comunit\u00e0ria","f\u00e0rmacs biol\u00f2gics","farmaeconomia","Formaci\u00f3","indicacions terap\u00e8utiques","Oficina de farm\u00e0cia","toxina botul\u00ednica","toxina botul\u00ednica a","toxines"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/","url":"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/","name":"Toxina botul\u00ednica A: aspectes diferencials entre diverses presentacions - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Toxines-botuliniques_280422_3-1024x574-1.jpg","datePublished":"2022-05-06T12:37:05+00:00","dateModified":"2023-10-10T07:17:56+00:00","description":"El passat 28 d'abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 \"Aspectes diferencials entre diverses presentacions de toxina botul\u00ednica A\" amb l'objectiu de saber diferenciar les diferents formulacions, con\u00e8ixer les indicacions de cada presentaci\u00f3 i comprendre les difer\u00e8ncies farmaecon\u00f2miques.","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Toxines-botuliniques_280422_3-1024x574-1.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Toxines-botuliniques_280422_3-1024x574-1.jpg","width":1024,"height":574},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2022\/05\/06\/toxina-botulinica-a-aspectes-diferencials-entre-diverses-presentacions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Toxina botul\u00ednica A: aspectes diferencials entre diverses presentacions"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Toxines-botuliniques_280422_3-1024x574-1.jpg",1024,574,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Toxines-botuliniques_280422_3-1024x574-1-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Toxines-botuliniques_280422_3-1024x574-1-300x168.jpg",300,168,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Toxines-botuliniques_280422_3-1024x574-1-768x431.jpg",768,431,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Toxines-botuliniques_280422_3-1024x574-1.jpg",1024,574,false],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Toxines-botuliniques_280422_3-1024x574-1.jpg",1024,574,false],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Toxines-botuliniques_280422_3-1024x574-1.jpg",1024,574,false],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Toxines-botuliniques_280422_3-1024x574-1.jpg",18,10,false]},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 28 d&#8217;abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 &#8220;Aspectes diferencials entre diverses presentacions de toxina botul\u00ednica A&#8221;, patrocinada per Ipsen. David Conde, vocal d&#8217;Hospitals del COFB, va ser l&#8217;encarregat de coordinar aquesta sessi\u00f3, que va comptar amb la participaci\u00f3 de M. Teresa [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/63375","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=63375"}],"version-history":[{"count":4,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/63375\/revisions"}],"predecessor-version":[{"id":69046,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/63375\/revisions\/69046"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/67914"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=63375"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=63375"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=63375"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}